Overview
Shuki Mizutani practices practicing medicine in Tokyo, Japan.
Mizutani is highly rated in 7 conditions, according to our data. Their clinical expertise encompasses Infantile-Onset Spinocerebellar Ataxia (IOSCA), Ataxia-Telangiectasia, Leukemia, Nijmegen Breakage Syndrome, and Bone Marrow Transplant.
They are actively involved in clinical research, co-authoring 80 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Shuki Mizutani
Is Shuki Mizutani a top-rated expert for Infantile-Onset Spinocerebellar Ataxia (IOSCA)?
MediFind is an objective health platform that identifies experts based on real-world data. Shuki Mizutani is classified as an Advanced expert for Infantile-Onset Spinocerebellar Ataxia (IOSCA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Shuki Mizutani participate in research or clinical trials?
Yes. Shuki Mizutani has published 80 articles and abstracts on conditions like Infantile-Onset Spinocerebellar Ataxia (IOSCA). You can view a list of Shuki Mizutani's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Ataxia-TelangiectasiaMizutani isAdvanced. Learn about Ataxia-Telangiectasia.
- Febrile NeutropeniaMizutani isAdvanced. Learn about Febrile Neutropenia.
- Infantile-Onset Spinocerebellar Ataxia (IOSCA)
- LeukemiaMizutani isAdvanced. Learn about Leukemia.
- Leukemoid ReactionMizutani isAdvanced. Learn about Leukemoid Reaction.
- Nijmegen Breakage SyndromeMizutani isAdvanced. Learn about Nijmegen Breakage Syndrome.
- Experienced
- Acute Myeloid Leukemia (AML)Mizutani isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Atelosteogenesis Type 1Mizutani isExperienced. Learn about Atelosteogenesis Type 1.
- Bone Marrow TransplantMizutani isExperienced. Learn about Bone Marrow Transplant.
- Childhood Acute Myeloid LeukemiaMizutani isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelogenous Leukemia (CML)Mizutani isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Congenital Adrenal Hyperplasia (CAH)
- Down SyndromeMizutani isExperienced. Learn about Down Syndrome.
- Drug Induced DyskinesiaMizutani isExperienced. Learn about Drug Induced Dyskinesia.
- DysarthriaMizutani isExperienced. Learn about Dysarthria.
- Embryonal Tumor with Multilayered Rosettes
- Hereditary AtaxiaMizutani isExperienced. Learn about Hereditary Ataxia.
- Infantile Axonal NeuropathyMizutani isExperienced. Learn about Infantile Axonal Neuropathy.
- Infantile NeutropeniaMizutani isExperienced. Learn about Infantile Neutropenia.
- IntersexMizutani isExperienced. Learn about Intersex.
- Langerhans Cell HistiocytosisMizutani isExperienced. Learn about Langerhans Cell Histiocytosis.
- NeuroblastomaMizutani isExperienced. Learn about Neuroblastoma.
- Primary Immunodeficiency (PID)Mizutani isExperienced. Learn about Primary Immunodeficiency (PID).
- Severe Combined Immunodeficiency (SCID)
- T-Cell LymphomaMizutani isExperienced. Learn about T-Cell Lymphoma.
- TelangiectasiaMizutani isExperienced. Learn about Telangiectasia.
- Wilms TumorMizutani isExperienced. Learn about Wilms Tumor.
- X-Linked Severe Combined Immunodeficiency